Muna Therapeutics

GSK is to work with Muna Therapeutics to discover novel therapies for neurodegenerative conditions such as Alzheimer’s disease, by exploiting new technologies which shed light on why some brains succ

Who: GSK and Relation Therapeutics What: The UK major has linked up with fellow London-based group Relation on two “multi-program strategic collaborations” which will focus on the identification an

Alzheimer’s disease is top of mind due to the millions of people in need of effective treatments and the rapid rise in the AD population globally – and because the first disease-modifying therapy has

With understanding of immune function advancing in leaps and bounds and a continuing proliferation of tools to manipulate it, expectations are high for advances in oncology and immunology over the com